CD38 and Miyoshi myopathy: In this study miR-26a was found to act by targeting CD38, a cell-surface glycoprotein involved in MM cells invasion and metastasis, resulting both in the induction of apoptosis in vitro and drug sensitization of MM tumors in vivo (Hu et al., 2020).